Neutral Polymeric Binding Agent Synthesis Without Hazardous Diisocyanates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing binding agents for solid composite propellants, such as NPBA, pose safety concerns due to the use of hazardous diisocyanates and are not compliant with REACH regulations, necessitating a safer and compliant alternative for use in energetic materials.
Innovation Solution
A one-pot synthesis process using carbonyldiimidazole and propargylamine to produce a compound of formula (I), which involves reacting a compound of formula (II) with an excess of carbonyldiimidazole followed by propargylamine, in the presence of specific solvents, to yield a neutral polymeric binding agent compatible with energetic materials.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If diisocyanates are used to synthesize NPBA binding agents, then the mechanical properties and binding performance are improved, but the safety and regulatory compliance deteriorate due to hazardous nature and REACH regulation violations
Solution Approach 1:
The patent uses carbonyldiimidazole as an intermediary reagent to convert compound (II) into the desired binding agent structure without requiring diisocyanates. This intermediary approach allows the synthesis to proceed through a safer chemical pathway while maintaining the functional properties needed for mechanical strength and binding performance in propellant formulations
Solution Approach 2:
The invention changes the chemical parameters of the synthesis process by replacing diisocyanate reagents with carbonyldiimidazole and compound (II), fundamentally altering the reaction pathway to eliminate hazardous substances while preserving the essential functional groups and molecular structure required for achieving adequate mechanical properties
2Object-affected harmful factors
If a multi-step synthesis process is used to avoid hazardous reagents, then the safety improves, but the manufacturing complexity and time increase
Solution Approach 1:
The patent merges multiple synthesis steps into a single streamlined process where carbonyldiimidazole reacts with compound (II) in one operation to directly produce the desired binding agent structure. This consolidation eliminates intermediate isolation steps and reduces manufacturing complexity while maintaining safety by avoiding hazardous reagents throughout the process
3Productivity
If hazardous diisocyanates are used, then the synthesis efficiency is maintained, but the purification difficulty and safety risks increase
Solution Approach 1:
Carbonyldiimidazole serves as a benign intermediary that reacts with compound (II) to form the desired product without generating hazardous byproducts. This intermediary approach simplifies purification by eliminating the need to remove toxic diisocyanate residues and their decomposition products, while maintaining high synthesis efficiency through direct chemical transformation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves quantitative yields, uses low-toxicity reagents, facilitates easy purification, and results in a compound suitable for energetic materials, adhering to REACH regulations.
Implementation Method 1
reacting a compound of formula (II) with an excess of carbonyldiimidazole
Implementation Method 2
reacting the compound obtained in step a) with an excess of propargylamine
Data Source
AI summary
A process for the synthesis of a compound of formula (I):wherein w, x, y and z are as defined in the description.The process includes reacting a compound of formula (II):with carbonyldiimidazole, and reacting the resulting compound with propargylamine.